Skip to main content
SpringerLink
Log in

Clinical Application of Preconditioning and Postconditioning to Achieve Neuroprotection

  • Review Article
  • Published:
Translational Stroke Research Aims and scope Submit manuscript

Abstract

Ischemic conditioning is a form of endogenous protection induced by transient, subcritical ischemia in a tissue. Organs with high sensitivity to ischemia, such as the heart, the brain, and spinal cord, represent the most critical and potentially promising targets for potential therapeutic applications of ischemic conditioning. Numerous preclinical investigations have systematically studied the molecular pathways and potential benefits of both pre- and postconditioning with promising results. The purpose of this review is to summarize the present knowledge on cerebral pre- and postconditioning, with an emphasis in the clinical application of these forms of neuroprotection. A systematic MEDLINE search for the terms preconditioning and postconditioning was performed. Publications related to the nervous system and to human applications were selected and analyzed. Pre- and postconditioning appear to provide similar levels of neuroprotection. The preconditioning window of benefit can be subdivided into early and late effects, depending on whether the effect appears immediately after the sublethal stress or with a delay of days. In general, early effects have been associated posttranslational modification of critical proteins (membrane receptors, mitochondrial respiratory chain) while late effects are the result of gene up- or downregulation. Transient ischemic attacks appear to represent a form of clinically relevant preconditioning by inducing ischemic tolerance in the brain and reducing the severity of subsequent strokes. Remote forms of ischemic pre- and postconditioning have been more commonly used in clinical studies, as the remote application reduces the risk of injuring the target tissue for which protection is pursued. Limb transient ischemia is the preferred method of induction of remote conditioning with evidence supporting its safety. Clinical studies in a variety of populations at risk of central nervous damage including carotid disease, cervical myelopathy, and subarachnoid hemorrhage have shown improvement in surrogate markers of injury. Promising preclinical and early clinical studies noting improvement in surrogate markers of central nervous injury after the use of remote pre- and postconditioning treatments demand follow-up systematic investigations to address effectiveness. Challenges in the application of these techniques to pressing clinical cerebrovascular disease ought to be overcome through careful, well-designed, translational investigations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Murry C, Jennings R, Reimer K. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124–36.

    Article  PubMed  CAS  Google Scholar 

  2. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, et al. ‘Ischemic tolerance’ phenomenon found in the brain. Brain Res. 1990;528(1):21–4.

    Article  PubMed  CAS  Google Scholar 

  3. Durukan A, Tatlisumak T. Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection. Exp Transl Stroke Med. 2010;2(1):2.

    Article  PubMed  Google Scholar 

  4. Zhao H, Ren C, Chen X, Shen J. From rapid to delayed and remote postconditioning: the evolving concept of ischemic postconditioning in brain ischemia. Curr Drug Targets. 2012;13(2):173–87.

    Article  PubMed  CAS  Google Scholar 

  5. Na HS, Kim YI, Yoon YW, Han HC, Nahm SH, Hong SK. Ventricular premature beat-driven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia. Am Heart J. 1996;132(1 Pt 1):78–83.

    Article  PubMed  CAS  Google Scholar 

  6. Zhao H, Sapolsky RM, Steinberg GK. Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab. 2006;26(9):1114–21.

    PubMed  CAS  Google Scholar 

  7. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res. 2010;87(3):406–23. doi:10.1093/cvr/cvq129.

    Article  PubMed  CAS  Google Scholar 

  8. Sandu N, Schaller B. Postconditioning: a new or old option after ischemic stroke? Expert Rev Cardiovasc Ther. 2010;8(4):479–82. doi:10.1586/erc.09.180.

    Article  PubMed  Google Scholar 

  9. Zhao Z-Q. Postconditioning in reperfusion injury: a status report. Cardiovasc Drugs Ther. 2010;24(3):265–79. doi:10.1007/s10557-010-6240-1.

    Article  PubMed  Google Scholar 

  10. Dirnagl U, Becker K, Meisel A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol. 2009;8(4):398–412.

    Article  PubMed  CAS  Google Scholar 

  11. Yu C, Beattie W. The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis. Can J Anesth/J Can d'anesthésie. 2006;53(9):906–18. doi:10.1007/bf03022834.

    Article  Google Scholar 

  12. Jneid H, Chandra M, Alshaher M, Hornung CA, Tang X-L, Leesar M, et al. Delayed preconditioning-mimetic actions of nitroglycerin in patients undergoing exercise tolerance tests. Circulation. 2005;111(20):2565–71. doi:10.1161/circulationaha.104.515445.

    Article  PubMed  CAS  Google Scholar 

  13. Bogousslavsky J, Regli F. Cerebral infarct in apparent transient ischemic attack. Neurology. 1985;35(10):1501–3.

    Article  PubMed  CAS  Google Scholar 

  14. Arboix A, Cabeza N, Garcia-Eroles L, Massons J, Oliveres M, Targa C, et al. Relevance of transient ischemic attack to early neurological recovery after nonlacunar ischemic stroke. Cerebrovasc Dis. 2004;18(4):304–11. doi:10.1159/000080356.

    Article  PubMed  CAS  Google Scholar 

  15. Della Morte D, Abete P, Gallucci F, Scaglione A, D'Ambrosio D, Gargiulo G, et al. Transient ischemic attack before nonlacunar ischemic stroke in the elderly. J Stroke Cerebrovasc Dis. 2008;17(5):257–62. doi:10.1016/j.jstrokecerebrovasdis.2008.03.004.

    Article  PubMed  Google Scholar 

  16. Schaller B. Ischemic preconditioning as induction of ischemic tolerance after transient ischemic attacks in human brain: its clinical relevance. Neurosci Lett. 2005;377(3):206–11. doi:10.1016/j.neulet.2004.12.004.

    Article  PubMed  CAS  Google Scholar 

  17. Wegener S, Gottschalk B, Jovanovic V, Knab R, Fiebach JB, Schellinger PD, et al. Transient ischemic attacks before ischemic stroke: preconditioning the human brain? Stroke. 2004;35(3):616–21. doi:10.1161/01.str.0000115767.17923.6a.

    Article  PubMed  Google Scholar 

  18. Weih M, Kallenberg K, Bergk A, Dirnagl U, Harms L, Wernecke KD, et al. Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? Stroke. 1999;30(9):1851–4.

    Article  PubMed  CAS  Google Scholar 

  19. Moncayo J, de Freitas GR, Bogousslavsky J, Altieri M, van Melle G. Do transient ischemic attacks have a neuroprotective effect? Neurology. 2000;54(11):2089–94.

    Article  PubMed  CAS  Google Scholar 

  20. Johnston SC. Ischemic preconditioning from transient ischemic attacks? Stroke. 2004;35(11 suppl 1):2680–2. doi:10.1161/01.STR.0000143322.20491.0f.

    Article  PubMed  Google Scholar 

  21. Andreotti F, Pasceri V, Hackett DR, Davies GJ, Haider AW, Maseri A. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med. 1996;334(1):7–12. doi:10.1056/NEJM199601043340102.

    Article  PubMed  CAS  Google Scholar 

  22. Ottani F, Galvani M, Ferrini D, Sorbello F, Limonetti P, Pantoli D, et al. Prodromal angina limits infarct size: a role for ischemic preconditioning. Circulation. 1995;91(2):291–7.

    Article  PubMed  CAS  Google Scholar 

  23. Abete P, Ferrara N, Cacciatore F, Madrid A, Bianco S, Calabrese C, et al. Angina-induced protection against myocardial infarction in adult and elderly patients: a loss of preconditioning mechanism in the aging heart? J Am Coll Cardiol. 1997;30(4):947–54. doi:10.1016/s0735-1097(97)00256-8.

    Article  PubMed  CAS  Google Scholar 

  24. He Z, Crook JE, Meschia JF, Brott TG, Dickson DW, McKinney M. Aging blunts ischemic-preconditioning-induced neuroprotection following transient global ischemia in rats. Curr Neurovasc Res. 2005;2(5):365–74.

    Article  PubMed  CAS  Google Scholar 

  25. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther. 2007;116(2):173–91. doi:10.1016/j.pharmthera.2007.06.005.

    Article  PubMed  CAS  Google Scholar 

  26. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis. 2009;204(2):334–41. doi:10.1016/j.atherosclerosis.2008.10.029.

    Article  PubMed  CAS  Google Scholar 

  27. Perez-Pinzon MA, Stetler RA, Fiskum G. Novel mitochondrial targets for neuroprotection. J Cereb Blood Flow Metab. 2012;32(7):1362–76.

    Article  PubMed  CAS  Google Scholar 

  28. Loukogeorgakis SP, Panagiotidou AT, Broadhead MW, Donald A, Deanfield JE, MacAllister RJ. Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system. J Am Coll Cardiol. 2005;46(3):450–6. doi:10.1016/j.jacc.2005.04.044.

    Article  PubMed  CAS  Google Scholar 

  29. Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002;106(23):2881–3.

    Article  PubMed  CAS  Google Scholar 

  30. Loukogeorgakis SP, Panagiotidou AT, Yellon DM, Deanfield JE, MacAllister RJ. Postconditioning protects against endothelial ischemia-reperfusion injury in the human forearm. Circulation. 2006;113(7):1015–9. doi:10.1161/CIRCULATIONAHA.105.590398.

    Article  PubMed  Google Scholar 

  31. Ren C, Gao X, Niu G, Yan Z, Chen X, Zhao H. Delayed postconditioning protects against focal ischemic brain injury in rats. PLoS One. 2008;3(12):e3851.

    Article  PubMed  Google Scholar 

  32. Burda J, Danielisová V, Némethová M, Gottlieb M, Matiašová M, Domoráková I, et al. Delayed postconditionig initiates additive mechanism necessary for survival of selectively vulnerable neurons after transient ischemia in rat brain. Cell Mol Neurobiol. 2006;26(7):1139–49. doi:10.1007/s10571-006-9036-x.

    Article  Google Scholar 

  33. Danielisova V, Nemethova M, Gottlieb M, Burda J. The changes in endogenous antioxidant enzyme activity after postconditioning. Cell Mol Neurobiol. 2006;26(7–8):1181–91. doi:10.1007/s10571-006-9034-z.

    PubMed  CAS  Google Scholar 

  34. Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, et al. Long-term benefit of postconditioning. Circulation. 2008;117(8):1037–44. doi:10.1161/circulationaha.107.729780.

    Article  PubMed  CAS  Google Scholar 

  35. Argaud L, Rioufol G, Lièvre M, Bontemps L, Legalery P, Stumpf M, et al. Preconditioning during coronary angioplasty: no influence of collateral perfusion or the size of the area at risk. Eur Hear J. 2004;25(22):2019–25. doi:10.1016/j.ehj.2004.07.040.

    Article  Google Scholar 

  36. Oppenheim C, Lamy C, Touze E, Calvet D, Hamon M, Mas JL, et al. Do transient ischemic attacks with diffusion-weighted imaging abnormalities correspond to brain infarctions? AJNR Am J Neuroradiol. 2006;27(8):1782–7.

    PubMed  CAS  Google Scholar 

  37. Sommer C. Ischemic preconditioning: postischemic structural changes in the brain. J Neuropathol Exp Neurol. 2008;67(2):85–92. doi:10.1097/nen.0b013e3181630ba6.

    Article  PubMed  CAS  Google Scholar 

  38. Tomida S, Nowak Jr TS, Vass K, Lohr JM, Klatzo I. Experimental model for repetitive ischemic attacks in the gerbil: the cumulative effect of repeated ischemic insults. J Cereb Blood Flow Metab. 1987;7(6):773–82.

    Article  PubMed  CAS  Google Scholar 

  39. Koch S, Katsnelson M, Dong C, Perez-Pinzon M. Remote ischemic limb preconditioning after subarachnoid hemorrhage. Stroke. 2011;42(5):1387–91. doi:10.1161/strokeaha.110.605840.

    Article  PubMed  Google Scholar 

  40. Kitano H, Young JM, Cheng J, Wang L, Hurn PD, Murphy SJ. Gender-specific response to isoflurane preconditioning in focal cerebral ischemia. J Cereb Blood Flow Metab. 2007;27(7):1377–86. doi:10.1038/sj.jcbfm.9600444.

    Article  PubMed  CAS  Google Scholar 

  41. Song X, Li G, Vaage J, Valen G. Effects of sex, gonadectomy, and oestrogen substitution on ischaemic preconditioning and ischaemia-reperfusion injury in mice. Acta Physiol Scand. 2003;177(4):459–66.

    Article  PubMed  CAS  Google Scholar 

  42. Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, Densem CG, et al. Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial. Circulation. 2009;119(6):820–7. doi:10.1161/circulationaha.108.809723.

    Article  PubMed  Google Scholar 

  43. Die J, Wang K, Fan L, Jiang Y, Shi Z. Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions. Brain Res. 2010;1346:251–61. doi:10.1016/j.brainres.2010.05.068.

    Article  PubMed  CAS  Google Scholar 

  44. Domoki F, Kis B, Gáspár T, Snipes JA, Parks JS, Bari F, et al. Rosuvastatin induces delayed preconditioning against oxygen-glucose deprivation in cultured cortical neurons. Am J Physiol - Cell Physiol. 2009;296(1):C97–C105. doi:10.1152/ajpcell.00366.2008.

    Article  PubMed  CAS  Google Scholar 

  45. Bilgin-Freiert A, Dusick JR, Stein NR, Etchepare M, Vespa P, Gonzalez NR. Muscle Microdialysis to Confirm Sublethal Ischemia in the Induction of Remote Ischemic Preconditioning. Translational Stroke Research. 2012:1–7.

  46. Walsh SR, Tang T, Sadat U, Dutka DP, Gaunt ME. Cardioprotection by remote ischaemic preconditioning. Br J Anaesth. 2007;99(5):611–6. doi:10.1093/bja/aem273.

    Article  PubMed  CAS  Google Scholar 

  47. Walsh SR, Nouraei SA, Tang TY, Sadat U, Carpenter RH, Gaunt ME. Remote ischemic preconditioning for cerebral and cardiac protection during carotid endarterectomy: results from a pilot randomized clinical trial. Vasc Endovasc Surg. 2010;44(6):434–9. doi:10.1177/1538574410369709.

    Article  Google Scholar 

  48. Hu S, Dong H-l, Li Y-z, Luo Z-j, Sun L, Yang Q-z, et al. Effects of remote ischemic preconditioning on biochemical markers and neurologic outcomes in patients undergoing elective cervical decompression surgery: a prospective randomized controlled trial. J Neurosurg Anesthesiol. 2010;22(1):46–52. 10.1097/ANA.0b013e3181c572bd.

    Article  PubMed  Google Scholar 

  49. Jensen HA, Loukogeorgakis S, Yannopoulos F, Rimpilainen E, Petzold A, Tuominen H, et al. Remote ischemic preconditioning protects the brain against injury after hypothermic circulatory arrest. Circulation. 2011;123(7):714–21. doi:10.1161/circulationaha.110.986497.

    Article  PubMed  CAS  Google Scholar 

  50. Gonzalez NR, Hamilton R, Bilgin-Freiert A, Dusick J, Vespa P, Hu X, et al. Cerebral hemodynamic and metabolic effects of remote ischemic preconditioning in patients with subarachnoid hemorrhage. Acta Neurochir Suppl. 2013;115:193–8. doi:10.1007/978-3-7091-1192-5_36.

    PubMed  Google Scholar 

  51. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics—2010 update. A Report From the American Heart Association. Circulation. 2009. doi:10.1161/circulationaha.109.192667. CIRCULATIONAHA.109.192667.

Download references

Conflict of Interest

CD was supported by NINDS K08 NS069817. NRG's research was sponsored by the Ruth and Raymond Stotter Chair Endowment in Neurosurgery.

Author information

Authors and Affiliations

  1. Department of Critical Care Medicine, Safar Center for Resuscitation Research, Vascular Medicine Institute, University of Pittsburgh School of Medicine, 100 Hill Building, 3434 Fifth Avenue, Pittsburgh, PA, 15260, USA

    Cameron Dezfulian

  2. David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

    Matthew Garrett & Nestor R. Gonzalez

Authors
  1. Cameron Dezfulian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthew Garrett
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nestor R. Gonzalez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cameron Dezfulian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dezfulian, C., Garrett, M. & Gonzalez, N.R. Clinical Application of Preconditioning and Postconditioning to Achieve Neuroprotection. Transl. Stroke Res. 4, 19–24 (2013). https://doi.org/10.1007/s12975-012-0224-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12975-012-0224-3

Keywords

Search

Navigation